Cumulative Irritation Test

The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.

 

Condition Intervention Phase
Onychomycosis Drug: AN2690
Other: AN2690 Solution, Vehicle
Other: Sodium Lauryl Sulfate, 0.5%		 Phase 1

 
Study Type: Interventional
Study Design: Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: 21-Day Cumulative Irritation Test

Date of article/Start date of trial: 8 May 2008

Trial Phase: Phase 1

clinical Trials Gov ID: NCT00680095

Trial status: Completed

Back to New Antifungals